Clinical Trial Update: Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Off-pump Coronary Artery Bypass Graft

View source ↗

Summary

This clinical trial assessed whether High Mobility Group Box 1 (HMGB1) can serve as a prognostic biomarker in patients undergoing off-pump coronary artery bypas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Occlusive Disease | Status: COMPLETED